Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Ultrasensitive MRD Profiling Predicts Outcomes in DLBCL after Frontline Therapy with Tafasitamab in Combination with Lenalidomide and R-CHOP
November 15, 2022 | Presentation
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-cell Lymphoma
April 29, 2022 | Poster
Inferring gene expression from cell-free DNA fragmentation profiles
April 1, 2022 | Manuscript
Nature Biopharma Dealmakers: Closing the gap on minimal residual disease detection in cancer
March 29, 2022 | Article
Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing
December 13, 2021 | Abstract
Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
December 13, 2021 | Abstract